Full Text View
Tabular View
No Study Results Posted
Related Studies
Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions
This study has been completed.
Study NCT00116064   Information provided by University of Malawi College of Medicine
First Received: June 26, 2005   Last Updated: July 20, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Status Epilepticus
Convulsions
Additional conditions recognized in this trial
Seizures
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Epilepsy
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Interventions listed in this trial
intranasal lorazepam
intramuscular paraldehyde
Additional drug interventions recognized in this trial
Lorazepam
Paraldehyde
More general drug interventions related to this trial
Anti-Anxiety Agents
Anticonvulsants
Antiemetics
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Gastrointestinal Agents
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Malawi College of Medicine


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services